Surgical Innovations Group plc provided earnings guidance for the full year ending December 31, 2014. For the period, the board expects that the company will report a significant loss before tax. Against this backdrop, short-term working capital funding and cash generation remains the board's key priority and further updates will be provided to shareholders as appropriate.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 GBX | 0.00% | -10.00% | -25.00% |
10/06 | Surgical Innovations names Weir's Chris Martin as CFO | AN |
10/06 | Surgical Innovations Group Appoints CFO | MT |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.00% | 5.32M | |
-5.81% | 180B | |
-1.63% | 106B | |
-4.14% | 67.55B | |
-6.56% | 46.11B | |
+13.22% | 45.79B | |
+6.13% | 41.61B | |
+19.93% | 31.07B | |
+13.61% | 24.77B | |
-5.36% | 24.27B |
- Stock Market
- Equities
- SUN Stock
- News Surgical Innovations Group plc
- Surgical Innovations Group plc Provides Earnings Guidance for the Full Year Ending December 31, 2014